Pharming Group N.V annual free cash flow
2019
2020
2021
2022
2023
2024
2025
Pharming Group N.V Free Cash Flow (FCF) History (PHAR)
Pharming Group N.V reported $54.0M in free cash flow for fiscal 2025, an increase of $56.5M from the previous fiscal year, with a free cash flow margin of 14.35%.
View full Pharming Group N.V company overviewPharming Group N.V free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $54.0M | $56.5M | — | +14.35% |
| 2024 | 2024-12-31 | −$2.6M | $16.2M | — | −0.87% |
| 2023 | 2023-12-31 | −$18.7M | −$39.8M | — | −7.64% |
| 2022 | 2022-12-31 | $21.1M | −$6.0M | −22.22% | +10.25% |
| 2021 | 2021-12-31 | $27.1M | −$51.9M | −65.68% | +13.63% |
| 2020 | 2020-12-31 | $79.0M | $7.5M | +10.44% | +37.22% |
| 2019 | 2019-12-31 | $71.5M | — | — | +37.75% |
Pharming Group N.V quarterly free cash flow
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$9.7M | −$21.4M | — | −10.80% |
| Q1 2026 | 2026-03-31 | $1.7M | — | — | +2.37% |
| Q4 2025 | 2025-12-31 | $10.4M | — | — | +9.80% |
| Q3 2025 | 2025-09-30 | $32.0M | — | — | +32.85% |
| Q2 2025 | 2025-06-30 | $11.6M | — | — | +12.46% |
Pharming Group N.V free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $79.0M to $54.0M, a compound annual decline of 7.33%. Pharming Group N.V's latest reported quarter, Q2 2026, generated −$9.7M in free cash flow, a decrease of $21.4M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Pharming Group N.V source filings ↗Community posts
Pharming secures priority review for lower-dose pediatric Joenja
Pharming ($PHAR) said the FDA accepted its supplemental application for a lower-dose Joenja formulation and granted priority review. The proposed expansion addresses patients aged four and older with activated PI3K delta syndrome who weigh ...
Pharming expands Joenja approval to younger children with APDS
Pharming ($PHAR) secured FDA approval to use Joenja in children aged four to 11 with activated PI3K delta syndrome who weigh at least 27 kilograms. The expansion adds younger patients to the medicine’s existing indication for older patients ...
